JFNIX
Price
$73.15
Change
+$0.07 (+0.10%)
Updated
Oct 2 closing price
Net Assets
4.49B
RYHCX
Price
$91.77
Change
+$0.35 (+0.38%)
Updated
Oct 2 closing price
Net Assets
23.59M
Interact to see
Advertisement

JFNIX vs RYHCX

Header iconJFNIX vs RYHCX Comparison
Open Charts JFNIX vs RYHCXBanner chart's image
Janus Henderson Global Life Sciences I
Price$73.15
Change+$0.07 (+0.10%)
VolumeN/A
Net Assets4.49B
Rydex Health Care C
Price$91.77
Change+$0.35 (+0.38%)
VolumeN/A
Net Assets23.59M
JFNIX vs RYHCX Comparison Chart in %
View a ticker or compare two or three
VS
JFNIX vs. RYHCX commentary
Oct 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and RYHCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.49B vs. RYHCX (23.6M). JFNIX pays higher dividends than RYHCX: JFNIX (0.38) vs RYHCX (0.00). JFNIX was incepted earlier than RYHCX: JFNIX (16 years) vs RYHCX (25 years). RYHCX (2.43) is less costly to investors than JFNIX (0.77). RYHCX is a more actively managed with annual turnover of: 236.00 vs. JFNIX (35.00). JFNIX (2500) and RYHCX (2500) have matching initial minimum investment requirements. RYHCX annual gain was more profitable for investors over the last year : -2.14 vs. JFNIX (-8.58). JFNIX return over 5 years is better than : 12.55 vs. RYHCX (6.14).
JFNIXRYHCXJFNIX / RYHCX
Total Expense Ratio0.772.3832%
Annual Report Gross Expense Ratio0.772.4332%
Fund Existence16 years25 years-
Gain YTD7.4396.513114%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.49B23.6M19,004%
Annual Yield % from dividends0.380.00-
Returns for 1 year-8.58-2.14401%
Returns for 3 years22.3518.76119%
Returns for 5 years12.556.14204%
Returns for 10 years37.619.07415%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AHSAX20.16N/A
N/A
Alger Health Sciences A
IVOCX19.89N/A
N/A
Macquarie Mid Cap Income Opps C
HFYYX13.36N/A
N/A
Hartford Schroders Intl Multi-Cp Val Y
AGWUX69.25N/A
N/A
American Century Growth R5
KMKCX75.40N/A
N/A
Kinetics Market Opportunities Adv C